Canadian Multicenter Chronic Total Occlusion Registry: Ten-Year Follow-Up Results of Chronic Total Occlusion Revascularization

医学 传统PCI 血运重建 经皮冠状动脉介入治疗 心脏病学 内科学 急性冠脉综合征 外科 动脉 心肌梗塞
作者
Bradley H. Strauss,Merril L. Knudtson,Asim N. Cheema,P. Diane Galbraith,Gabby Elbaz‐Greener,Wael Abuzeid,Kayley A. Henning,Feng Qiu,Harindra C. Wijeysundera
出处
期刊:Circulation-cardiovascular Interventions [Lippincott Williams & Wilkins]
卷期号:14 (12) 被引量:25
标识
DOI:10.1161/circinterventions.121.010546
摘要

Background: Chronic total occlusions (CTO) occur in nearly 20% of coronary angiograms. CTO revascularization, either by percutaneous coronary intervention (PCI) or coronary artery bypass grafting surgery (CABG), is infrequently performed, approximately one-third of cases. Long-term outcomes are unknown. The objective of the study was to determine whether early CTO revascularization of patients, either by CABG or PCI, was associated with improved clinical outcomes. Methods: One thousand six hundred twenty-four patients from the Canadian CTO registry were followed for at least 9.75 years. Revascularization was performed according to routine clinical practice. Patients were grouped according to CTO revascularization status (PCI or CABG of CTO vessel, CTO revasc) or no CTO revasc (medical therapy only, or PCI/CABG of non-CTO vessels only), within 3 months of initial angiogram. Patients were followed for mortality, revascularization procedures (PCI and CABG), and hospitalizations for acute coronary syndromes and heart failure. Results: Early CTO revasc was performed in 28.2% of patients (17.5% CABG, 10.7% PCI). The CTO revasc group was younger, with more males and generally fewer comorbidities. There was a significantly lower mortality probability at 10 years in the CTO revascularization group (22.7% [95% CI, 19.0%–26.9%]) compared with the no CTO revasc group (36.6% [95% CI, 33.8%–39.5%]). At 10 years, revascularization rates (14.0% versus 22.8%) and acute coronary syndrome hospitalization rates (10.0% versus 16.6%) were significantly lower in the CTO revasc group. Baseline-adjusted analysis showed CTO revasc was associated with significantly lower all-cause mortality (hazard ratio, 0.67 [95% CI, 0.54–0.84]). In both landmark and time varying analyses, association with lower mortality was particularly robust for CTO revascularization by CABG (hazard ratio 0.56 and 0.60, respectively), with a marginally significant result for PCI in the time varying analysis (hazard ratio 0.711 [95% CI, 0.51–0.998]). Conclusions: Early CTO revascularization was associated with significantly lower all-cause mortality, revascularization rates, and hospitalization for acute coronary syndrome at 10 years, and mainly driven by outcomes in patients with CABG.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
李富贵儿~完成签到,获得积分10
刚刚
nemo711完成签到,获得积分10
刚刚
123PY完成签到,获得积分10
1秒前
2秒前
0201发布了新的文献求助10
3秒前
3秒前
陶醉晓凡完成签到,获得积分10
3秒前
大白完成签到,获得积分10
3秒前
东方元语应助别管我是谁采纳,获得20
4秒前
dali完成签到 ,获得积分10
4秒前
creepppp完成签到,获得积分10
4秒前
科研狗发布了新的文献求助10
4秒前
楠D完成签到,获得积分0
4秒前
4秒前
旦皋完成签到 ,获得积分10
5秒前
5秒前
6秒前
香蕉觅云应助虚幻凌晴采纳,获得10
6秒前
鲨鱼完成签到,获得积分10
6秒前
7秒前
思源应助Bertha采纳,获得10
7秒前
murphy完成签到,获得积分10
7秒前
风中采枫完成签到,获得积分10
8秒前
从容白凝发布了新的文献求助10
8秒前
8秒前
creepppp发布了新的文献求助10
8秒前
9秒前
9秒前
10秒前
spring完成签到 ,获得积分10
10秒前
10秒前
crow发布了新的文献求助10
10秒前
Kao应助科研通管家采纳,获得10
11秒前
iNk应助科研通管家采纳,获得10
11秒前
李健应助科研通管家采纳,获得10
11秒前
乐乐应助科研通管家采纳,获得10
11秒前
meimei完成签到,获得积分10
12秒前
星辰大海应助科研通管家采纳,获得10
12秒前
12秒前
Orange应助科研通管家采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
An Introduction to Foreign Language Learning and Teaching 750
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
Les chinois de jakarta: temples et vie collective 500
The fast track to determining transfer functions of linear circuits: The student guide 500
What is the Future of Psychotherapy in Digital Age? Technology, AI Bots, and Psychotherapy after Covid 444
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7628265
求助须知:如何正确求助?哪些是违规求助? 9202658
关于积分的说明 19732289
捐赠科研通 7197919
什么是DOI,文献DOI怎么找? 3273952
关于科研通互助平台的介绍 2436259
邀请新用户注册赠送积分活动 2270145